These recommendations did not receive the media attention they deserved.
MiSight® 1 day’s FDA approval is an important step forward in stopping the myopia epidemic facing American children.
Results of a recent study on combining orthokeratology and topical atropine 0.01%.
When I speak with eye care professionals I am surprised by how much snake oil exists.
Jobson Optical Research, sponsored by Essilor, polled more than 300 optometrists in the U.S.
Myopia was once considered a simple refractive error with few, if any, long-term eye health consequences.
By Dwight Akerman, OD, MBA, FAAO Chief Medical Editor, Review of Myopia Management During May 2019, Jobson Optical Research, sponsored by Essilor,...
While we have much to learn about myopia management in children and teenagers, we already know so much.
Congratulations to all who created the International Myopia Institute (IMI) Myopia White Papers.
Thank you for your support for Review of Myopia Management.
The answer comes from articles written by leaders in myopia care.